Introduction
Malaria is a life-threatening parasitic disease caused by Plasmodium species and transmitted through the bite of infected female Anopheles mosquitoes. Globally, malaria continues to be a major public health problem, particularly in tropical and subtropical regions, with Africa accounting for over 90% of malaria-related deaths. Among the most vulnerable populations affected by malaria are women, particularly pregnant women, due to both biological and socio-cultural factors. Malaria in women is not just a medical issue; it is a significant public health concern that intersects with gender, health equity, and development.
Biological Susceptibility of Women to Malaria
While men and women are both at risk of malaria in endemic regions, women experience unique biological vulnerabilities. These differences are most pronounced during pregnancy, a condition that suppresses the immune system and increases susceptibility to infections, including malaria.
Malaria and Pregnancy
View this post on Instagram
Pregnancy-related malaria, often referred to as malaria in pregnancy (MiP), poses severe risks for both mother and fetus. During pregnancy, particularly in first-time mothers (primigravidae), women lose some of the immunity they may have acquired over time. This makes them more susceptible to Plasmodium falciparum, the most deadly malaria parasite. The placenta becomes a site for parasite sequestration, where the parasites adhere to placental tissue, evading the maternal immune system. This can lead to placental malaria, resulting in complications such as:
- Maternal anemia
- Preterm birth
- Low birth weight
- Stillbirth
- Neonatal mortality
In addition, malaria during pregnancy can increase the risk of maternal mortality, particularly in areas with limited access to healthcare.
Social and Cultural Factors
The burden of malaria in women is compounded by social and cultural norms that affect healthcare access and decision-making. In many malaria-endemic countries, women may have less access to information, resources, and healthcare services compared to men.
Barriers to Accessing Care
Women, especially in rural and impoverished communities, face several obstacles in accessing timely and adequate malaria prevention and treatment, such as:
- Financial dependency: Women may lack control over household finances and may not be able to afford treatment.
- Limited mobility: Cultural norms may restrict women from traveling alone to health facilities.
- Lack of education: Women with limited education may not recognize the symptoms of malaria or understand the importance of prevention measures like insecticide-treated nets (ITNs).
- Gender roles: Women often prioritize the health of their children and male relatives over their own, delaying treatment for themselves.
These social determinants significantly influence malaria outcomes in women, often leading to delayed diagnosis and treatment, which can exacerbate the severity of the disease.
Impact on Women’s Health
General Health Impact
In addition to the specific risks during pregnancy, malaria affects the general health of women in multiple ways. Repeated malaria infections can lead to chronic anemia, fatigue, and reduced productivity. In resource-limited settings, this can severely impact women’s ability to perform household duties, earn a livelihood, and care for their families.
Reproductive Health Consequences
Beyond the direct effects of MiP, malaria can impact a woman’s reproductive health. Studies have linked malaria to increased risk of miscarriage, infertility (through post-infectious complications), and other reproductive tract infections. Furthermore, co-infections with diseases like HIV can increase the severity of malaria and complicate reproductive health outcomes.
Malaria and Adolescent Girls
Adolescent girls, especially those who become pregnant during their teenage years, are at a heightened risk of severe malaria. Due to their underdeveloped immune systems and increased physiological needs during adolescence and early pregnancy, they are more susceptible to anemia and other complications from malaria. Unfortunately, they are often the least likely to receive adequate antenatal care, which includes preventive measures like intermittent preventive treatment in pregnancy (IPTp).
Prevention Strategies for Women
Efforts to combat malaria in women must be multifaceted, targeting both biological vulnerability and social inequality. Effective prevention strategies include:
1. Insecticide-Treated Nets (ITNs)
ITNs are one of the most effective tools in reducing malaria transmission. Women and children are prioritized in net distribution campaigns, but usage remains inconsistent due to cultural practices, discomfort, or damage to the nets. Education campaigns that promote consistent and correct use are essential.
2. Intermittent Preventive Treatment in Pregnancy (IPTp)
IPTp with sulfadoxine-pyrimethamine is a WHO-recommended intervention for preventing malaria during pregnancy in areas of moderate to high transmission. It involves administering antimalarial drugs during antenatal visits, regardless of whether the woman shows symptoms. Uptake of IPTp remains suboptimal in many countries due to poor antenatal care attendance, drug stock-outs, and lack of awareness.
3. Indoor Residual Spraying (IRS)
IRS involves spraying insecticides inside homes to kill mosquitoes. This strategy, when applied at a community level, can significantly reduce malaria transmission. For it to benefit women, it must be combined with education and acceptance within the community.
4. Health Education and Community Engagement
Empowering women with knowledge about malaria symptoms, prevention methods, and the importance of early treatment can significantly improve outcomes. Community-based health education programs tailored for women and girls can bridge the knowledge gap and encourage health-seeking behaviors.
Treatment Considerations for Women
Treatment of malaria in women, especially pregnant women, requires careful consideration of drug safety. Some antimalarial drugs are contraindicated in pregnancy, particularly in the first trimester. The WHO recommends specific treatment regimens:
- For uncomplicated malaria in the first trimester: Quinine plus clindamycin
- For uncomplicated malaria in the second and third trimesters: Artemisinin-based combination therapies (ACTs)
- For severe malaria at any stage of pregnancy: Intravenous artesunate
Ensuring that healthcare providers are trained in the safe treatment of malaria during pregnancy is critical to protecting both maternal and fetal health.
Global and Regional Interventions
Efforts to address malaria in women are supported by several international initiatives and organizations, including:
1. The Roll Back Malaria Partnership
This global framework for coordinated action includes specific objectives aimed at reducing malaria in pregnancy and improving women’s health outcomes. It promotes the integration of malaria prevention into maternal and child health programs.
2. WHO Global Technical Strategy for Malaria 2016–2030
This strategy emphasizes universal access to malaria prevention, diagnosis, and treatment, with a focus on vulnerable groups such as pregnant women.
3. National Malaria Control Programs (NMCPs)
Many endemic countries have developed national strategies that incorporate malaria in pregnancy into broader maternal health programs. Successful examples include Malawi and Tanzania, which have improved IPTp coverage through focused antenatal interventions.
The Role of Gender Equity in Malaria Control
Gender equality is fundamental to achieving malaria control and elimination. Women must be recognized not just as beneficiaries of health interventions but also as agents of change. Engaging women in decision-making processes, training female community health workers, and addressing gender-based barriers to healthcare access are essential components of a gender-sensitive malaria response.
Research Gaps and Future Directions
There is a growing recognition of the need for gender-disaggregated data in malaria research. Current data often overlook the differences in malaria burden between men and women, especially regarding social determinants of health. Future research should focus on:
- The impact of malaria on adolescent girls and non-pregnant women
- Long-term effects of placental malaria on maternal and child health
- Innovative delivery systems for IPTp and ITNs
- Integration of malaria prevention into reproductive health and family planning services
Conclusion
Malaria in women is a multifaceted issue that intersects with biology, social norms, healthcare access, and gender inequality. While significant strides have been made in malaria control over the past two decades, women—especially pregnant women and adolescent girls—remain disproportionately affected. Targeted interventions, inclusive policies, and gender-sensitive healthcare systems are essential to reduce the burden of malaria in women. By prioritizing the health needs of women, particularly in endemic regions, the global health community can make substantial progress toward malaria elimination and gender equity in healthcare.